Blood test to find early signs of a transplant complication
Part of Blood & lymphatic clinical trials.
This trial looks for proteins in the blood that could help detect transplant-related blood vessel damage (called TMA) earlier, so doctors can treat it faster. It involves patients who have had a stem cell transplant from a donor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer or serious blood disorder (like leukemia or lymphoma).
- You have received or will receive a stem cell transplant from a donor.
- You are 14 years old or older.
- You or a family member can sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies patients who have had a stem cell or solid organ transplant and may have a condition called TMA (small blood clots in vessels) or a viral infection. It aims to understand how certain immune system parts (complement and interferon) affect these conditions.
This trial is for people with certain blood cancers or bone marrow disorders who need a stem cell transplant from a half-matched donor. It compares two different doses of a medicine that helps prevent the donor cells from attacking the body (graft-versus-host disease).
This trial checks if measuring a specific virus marker in your blood after a stem cell transplant can help predict or prevent transplant complications. You would have extra blood tests to guide your care.
This trial tests a new drug, TGD001, for a condition called thrombotic microangiopathy (TMA), where small blood clots form in blood vessels and damage organs. The drug aims to break up clots and improve blood flow.
This trial tests if a medication called etamsylate can help prevent bleeding in patients getting a stem cell transplant. If your platelet count drops very low after transplant, this drug may reduce your risk of bleeding.
This study looks at people who have a blood clotting problem called TMA after a stem cell transplant from a donor. It gathers information from routine checkups to learn more about this condition.
Hear when a new Thrombotic Microangiopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.